A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 24,220 shares of STTK stock, worth $30,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,220
Previous 24,920 2.81%
Holding current value
$30,032
Previous $223,000 58.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$3.56 - $11.18 $2,492 - $7,826
-700 Reduced 2.81%
24,220 $93,000
Q1 2024

Apr 29, 2024

SELL
$7.37 - $10.09 $78,859 - $107,963
-10,700 Reduced 30.04%
24,920 $223,000
Q3 2023

Nov 13, 2023

SELL
$1.42 - $3.16 $20,306 - $45,188
-14,300 Reduced 28.65%
35,620 $54,000
Q2 2023

Aug 15, 2023

SELL
$2.52 - $3.66 $34,473 - $50,068
-13,680 Reduced 21.51%
49,920 $156,000
Q1 2023

Apr 27, 2023

SELL
$2.5 - $4.72 $170,625 - $322,140
-68,250 Reduced 51.76%
63,600 $187,000
Q4 2022

Feb 07, 2023

SELL
$1.96 - $3.26 $75,656 - $125,835
-38,600 Reduced 22.65%
131,850 $303,000
Q3 2022

Oct 28, 2022

BUY
$2.6 - $5.52 $10,426 - $22,135
4,010 Added 2.41%
170,450 $460,000
Q2 2022

Aug 12, 2022

BUY
$2.7 - $4.59 $154,861 - $263,264
57,356 Added 52.58%
166,440 $676,000
Q1 2022

May 04, 2022

BUY
$4.22 - $8.89 $22,703 - $47,828
5,380 Added 5.19%
109,084 $465,000
Q4 2021

Feb 07, 2022

BUY
$8.36 - $21.08 $802,593 - $2.02 Million
96,004 Added 1246.81%
103,704 $883,000
Q3 2021

Nov 02, 2021

BUY
$17.57 - $28.95 $49,020 - $80,770
2,790 Added 56.82%
7,700 $157,000
Q2 2021

Aug 11, 2021

BUY
$24.14 - $37.68 $13,277 - $20,724
550 Added 12.61%
4,910 $142,000
Q1 2021

May 14, 2021

SELL
$27.92 - $52.5 $153,560 - $288,750
-5,500 Reduced 55.78%
4,360 $127,000
Q4 2020

Feb 16, 2021

BUY
$19.0 - $57.61 $187,340 - $568,034
9,860 New
9,860 $517,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $52.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.